Eisler Capital (US)’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-35,861
Closed -$833K 209
2024
Q2
$833K Buy
35,861
+1,381
+4% +$32.1K 0.01% 179
2024
Q1
$708K Buy
+34,480
New +$708K 0.02% 157